Acetaminophen (APAP)-Induced Liver Injury Models

Our validated acetaminophen (APAP)- induced hepatotoxicity model provides a physiologically relevant platform for rigorous preclinical evaluation of drug candidate safety profiles. This well-characterized system enables end-to-end services spanning customized model development, mechanistic toxicity studies, and comprehensive safety assessment solutions.

Download

What Can We Do Based on APAP-induced Liver Injury Models?

Leveraging our extensively validated drug-induced liver injury (DILI) platforms, we deliver fully customizable safety assessment solutions that encompass mechanistic model development, standardized hepatotoxicity screening, and integrated PK/PD- toxicology study designs.

Application of APAP-induced Liver Injury Models in Preclinical Research

Mechanism Research of Drug-Induced Liver Injury (DILI)
Development and Evaluation of Hepatoprotective Drugs
Drug Hepatotoxicity Risk Assessment

Fill In This Form to Get Details of Our Acetaminophen (APAP)-Induced Liver Injury Models.

Acetaminophen (APAP)-Induced Liver Injury Models

You might be interested in...